Press release
Generic Drugs Market Size Worth US$ 460.5 Billion during 2023-2028, With a CAGR of 6.83% | IMARC Group
Generic Drugs Market Overview:
Generic drugs are pharmaceutical products that are bioequivalent to branded medications in terms of dosage, quality, and performance. These drugs have the same active ingredients, intended use, route of administration, and therapeutic effects as their brand-name counterparts but are usually sold at a significantly lower price.
Characteristically, generic drugs undergo rigorous testing to ensure safety and efficacy before receiving approval from health authorities. Their working mechanism mimics that of the branded medications they are intended to replace, offering an economical yet effective alternative for patients. One of the primary advantages of generic drugs is the cost-saving benefit they offer, both to the healthcare system and to consumers, without compromising on quality or therapeutic effect.
Get Sample Copy of Report at - https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample
Generic Drugs Market Trends:
The Generic Drugs Market is primarily driven by the ever-increasing healthcare costs, pushing the need for affordable medication alternatives. In line with this, patent expirations of blockbuster drugs are creating opportunities for generic introductions. Moreover, an aging global population requiring prolonged medication is adding further impetus to the market. In addition to this, consumer awareness about cost-effective drug substitutes is expanding the user base for these products.
Besides this, the strong presence of bioequivalent drugs in the market supports physicians in prescribing more cost-effective options. Also, streamlined regulatory pathways for generic drug approval are expediting market entry. Some of the other factors contributing to the market are the robust growth in the pharmaceutical sector, heightened investment in research and development for drug formulation, greater penetration of generic drugs in emerging markets, and the ongoing efforts to reduce the gap between supply and demand for essential medicines.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/generic-drug-manufacturing-plant
Top Generic Drugs Companies Worldwide :
• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupin Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited
Key Market Segmentation:
Breakup by Drug Delivery:
• Oral
• Injectables
• Dermal/Topical
• Inhalers
Breakup by Therapy Area:
• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others
Breakup by Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
• Market Performance
• Market Outlook
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Also, Read More Blogs:
• Chocolate Companies: https://www.imarcgroup.com/chocolate-companies
• Virtual Events Companies: https://www.imarcgroup.com/virtual-events-companies
• Meat Substitutes Companies: https://www.imarcgroup.com/top-meat-substitutes-companies
• Precision Agriculture Companies: https://www.imarcgroup.com/precision-agriculture-companies
• E-Cigarette Companies: https://www.imarcgroup.com/e-cigarette-companies
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Drugs Market Size Worth US$ 460.5 Billion during 2023-2028, With a CAGR of 6.83% | IMARC Group here
News-ID: 3328693 • Views: …
More Releases from IMARC Group
Global Cellulose Prices Q2 2025 - Trend, News & Insights
North America Cellulose Prices Movement Q2
Cellulose Prices in United States:
In Q2 2025, US Cellulose Prices were pressured by reduced output at pulp mills due to maintenance and labor shortages. Timber harvesting delays from adverse weather constrained raw material supply. Steady demand from packaging and construction supported consumption, while rising fuel surcharges and logistics costs added to overall pricing challenges.
Get the Real-Time Prices Analysis: https://www.imarcgroup.com/cellulose-pricing-report/requestsample
APAC Cellulose Prices Movement Q2:
Cellulose Prices in…
E-Waste Manufacturing Plant Report 2025: Raw Materials Requirement, Setup Cost a …
E-Waste refers to discarded electronic devices such as computers, smartphones, televisions, and household appliances that have reached the end of their life cycle. It contains both valuable materials like gold, copper, and rare earth elements, as well as hazardous substances such as lead, mercury, and cadmium, making proper recycling crucial for environmental safety and resource recovery.
Setting up an e-waste recycling plant requires investment in land, machinery for dismantling and extraction,…
Cement Bricks Manufacturing Plant Report 2025: Business Plan, and Setup Details
Cement bricks are solid or hollow rectangular blocks made from a mixture of cement, sand, and aggregates, molded and cured for strength and durability. They are widely used in construction due to their uniform shape, load-bearing capacity, resistance to fire and weather, and cost-effectiveness compared to traditional clay bricks.
Setting up a cement bricks manufacturing plant involves securing land, installing machinery like mixers and molding units, sourcing raw materials, and employing…
Propyl Cyanoacetate Production Cost Report 2025: Detailed Guide on Plant Setup, …
Setting up a propyl cyanoacetate production facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Propyl Cyanoacetate Production Cost Analysis Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a propyl cyanoacetate…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
